Gilead Sciences (GILD)

R&D Expenses

$1.76B

Quarterly · Period ending: · USD

GILD logo

GILD R&D Expenses

Latest reported$1.76B
GILD Quarterly R&D Expenses ($0.00 → $1.76B)
High-resolution chart · PNG

GILD r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Gilead Sciences R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
1,764,000,000
1,372,000,000
1,584,000,000
1,346,000,000
1,491,000,000
1,379,000,000
1,641,000,000
1,395,000,000
1,351,000,000
1,520,000,000
1,408,000,000
1,457,000,000
1,407,000,000
1,447,000,000
-1,152,000,000
1,149,000,000
1,102,000,000
3,878,000,000
2,027,000,000
1,101,000,000
1,092,000,000
1,055,000,000
1,578,000,000
1,158,000,000
1,299,000,000
1,004,000,000
1,899,000,000
1,030,000,000
995,000,000
1,057,000,000
1,950,000,000
939,000,000
1,192,000,000
937,000,000
1,150,000,000
789,000,000
864,000,000
931,000,000
1,208,000,000
1,141,000,000
1,484,000,000
1,265,000,000
757,000,000
743,000,000
818,000,000
696,000,000
1,044,632,000
630,000,000
584,000,000
595,000,000
551,978,000
546,244,000
523,902,000
497,632,000
439,659,000
465,831,000
396,244,000
458,211,000
402,236,000
290,066,000
282,403,000
254,446,000
392,760,000
230,440,000
231,066,000
218,664,000
239,645,000
269,856,000
241,638,000
188,779,000
201,863,000
188,062,000
176,542,000
155,301,000
184,648,000
140,357,000
135,931,000
130,090,000
111,620,000
93,305,000
90,536,000
88,400,000
68,763,000
78,830,000
59,697,000
70,434,000
70,160,000
49,204,000
45,643,000
58,545,000
53,267,000
35,980,000
43,318,000
41,140,000
35,015,000
35,338,000
30,851,000
33,554,000
44,601,000
45,728,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.